Literature DB >> 9802618

It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients.

T Gruenberger1, M Gorlitzer, T Soliman, M Rudas, M Mittlboeck, M Gnant, A Reiner, B Teleky, W Seitz, R Jakesz.   

Abstract

The purpose of this study was the evaluation of the necessity of routinely applied postoperative radiotherapy in a highly selected patient-group after breast conserving surgery. Between 1983 and May 1994, 356 women over 60 years of age with Stage I or II breast cancer were treated by quadrantectomy and axillary dissection followed by either adjuvant irradiation or no radiotherapy. We have analysed our data retrospectively to investigate whether irradiation has any benefit in elderly patients with respect to locoregional recurrence rates. After a median follow-up of 60 months the multivariate model revealed lymph node status (p = 0.002) as highly significant with regard to local recurrence free survival. We were not able to identify a positive effect of adjuvant irradiation in patients with negative lymph nodes and positive receptor status: both patient groups with or without irradiation had similar locoregional recurrence rates of 3%. In a subgroup of patients who were lymph node negative, receptor positive, and received adjuvant tamoxifen therapy, the local recurrence rates were as low as 2% in both groups. Concerning these results it may be possible to avoid the morbidity and potential psychological side effects of radiotherapy in breast cancer patients over 60 years of age treated by breast conserving surgery (T1, N0, positive hormone receptor, adjuvant tamoxifen) without increasing risk of locoregional recurrence. These data have to be confirmed in a prospectively randomized fashion.

Entities:  

Mesh:

Year:  1998        PMID: 9802618     DOI: 10.1023/a:1006064608360

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  8 in total

1.  Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group.

Authors:  Raimund Jakesz; Hellmut Samonigg; Michael Gnant; Ernst Kubista; Dieter Depisch; Roland Kolb; Brigitte Mlineritsch; Hans-Jörg Mischinger; Rainer-Christian Menzel; Peter Steindorfer; Werner Kwasny; Christoph Tausch; Michael Stierer; Susanne Taucher; Michael Seifert; Hubert Hausmaninger
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

2.  A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up.

Authors:  Gabriele Martelli; Patrizia Boracchi; Michaela De Palo; Silvana Pilotti; Saro Oriana; Roberto Zucali; Maria Grazia Daidone; Giuseppe De Palo
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

3.  Survival after surgical treatment of breast cancer.

Authors:  Susanne Taucher; Raimund Jakesz
Journal:  Langenbecks Arch Surg       Date:  2004-02-18       Impact factor: 3.445

Review 4.  Effect of targeted agents on the endocrine response of breast cancer in the neoadjuvant setting: a systematic review.

Authors:  Antonino Grassadonia; Marta Caporale; Nicola Tinari; Marinella Zilli; Michele DeTursi; Teresa Gamucci; Patrizia Vici; Clara Natoli
Journal:  J Cancer       Date:  2015-05-12       Impact factor: 4.207

5.  Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial.

Authors:  Claire Lemanski; David Azria; Sophie Gourgou-Bourgade; Norbert Ailleres; Aurelie Pastant; Philippe Rouanet; Pascal Fenoglietto; Jean-Bernard Dubois; Marian Gutowski
Journal:  Radiat Oncol       Date:  2013-08-01       Impact factor: 3.481

6.  Successful management of elderly breast cancer patients treated without radiotherapy.

Authors:  Kalliope Valassiadou; David A L Morgan; John F R Robertson; Sarah E Pinder; Kwok-Leung Cheung
Journal:  World J Surg Oncol       Date:  2007-06-03       Impact factor: 2.754

7.  Conservative management of breast cancer in the elderly in a developing country.

Authors:  Lukas J Wasserman; Justus P Apffelstaedt; Jacobus de V Odendaal
Journal:  World J Surg Oncol       Date:  2007-10-01       Impact factor: 2.754

8.  Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer.

Authors:  Antonino Grassadonia; Marta Di Nicola; Simona Grossi; Paolo Noccioli; Saveria Tavoletta; Roberto Politi; Domenico Angelucci; Camilla Marinelli; Marinella Zilli; Giampiero Ausili Cefaro; Nicola Tinari; Michele De Tursi; Laura Iezzi; Pasquale Cioffi; Stefano Iacobelli; Clara Natoli; Ettore Cianchetti
Journal:  Ann Surg Oncol       Date:  2014-02-13       Impact factor: 5.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.